Log in to save to my catalogue

ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metasta...

ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metasta...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1b35ada8af264014af6e837a45dcee55

ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer

About this item

Full title

ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-02, Vol.13 (1), p.2078-2078, Article 2078

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Adenosine-to-inosine RNA editing is a process mediated by adenosine deaminases that act on the RNA (ADAR) gene family. It has been discovered recently as an epigenetic modification dysregulated in human cancers. However, the clinical significance of RNA editing in patients with liver metastasis from colorectal cancer (CRC) remains unclear. The curr...

Alternative Titles

Full title

ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1b35ada8af264014af6e837a45dcee55

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1b35ada8af264014af6e837a45dcee55

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-29397-z

How to access this item